Hansoh Pharmaceutical Group Company Limited (3692.HK)
Develops and sells medicines for infections, cancer, and other diseases across China.
33.48+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-4.1%
The outlook
Hansoh Pharmaceutical has strong analyst backing with a consensus "Strong Buy" rating across 22 coverage. The stock is trading near its 52-week lows with an average price target roughly 39% above current levels. Price action is mixed relative to moving averages, reflecting a stock caught between support and recent resistance.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 22 analysts
Price trendMixed vs its moving averages
52-week range34% of the way from its 52-week low to high
Price targetAvg target +39% vs current price
Analyst price target
~12-month · 22 analysts46.47average target+38.8% vs now
Now 33.48
Low 37.26High 52.88
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$202.99B
52-wk high
44.22
52-wk low
28.06
50-day avg
31.51
200-day avg
35.95
Trailing P/E
31.0